any deaths from semaglutide Reduces Cardiovascular and COVID Death Semaglutide: Double-edged Sword with Risks

We still dont know why people with diabetes (and obesity) dont lose as much weight compared with obesity without diabetes (as Drucker and I discussed in the companion podcast)

Additionally, we observed that TL had a negative relationship with allostatic load ( = .320 p = .017) and a cardiometabolic risk score ( = .300 p = .025)

Des., 13: 813-828

Ryan EH, Jr., Han DP, Ramsay RC, Cantrill HL, Bennett SR, Dev S, Williams DF

Broader adoption in the US would require either greater insurance coverage or price reductions to match international levels ($169 in Japan, $93 in the UK, and $87 in Australia for a 30-day supply)